— City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, today announced three new members to its board of directors: Barbara Bruser, senior managing director with First Republic Private Wealth Management, Steven B. Fink, former chief executive officer of Lawrence Investments LLC, and William J. Post, chairman of the board of Translational Genomics Research Institute (TGen).
“City of Hope’s new board members bring a wealth of senior-level experience, ideas and passion to our institution, and we are extremely grateful for their service,” said City of Hope President and Chief Executive Officer Robert W. Stone
. “They share our commitment to advancing leading-edge research and treatment in cancer, diabetes and other life-threatening diseases and delivering compassionate care to our patients.”
Bruser has a 40-year career in the investment industry. She started as an equity securities analyst for a large institutional firm and then transitioned to private client portfolio management. Bruser was senior vice president-regional director of alternative strategies with Bank of America, and senior vice president-director of equities with City National Bank. She has been in her recent position with First Republic Private Wealth Management since 2010.
Before joining the board, Bruser served on the Investment Committee of the City of Hope Board of Directors beginning in 2000. She is now the committee’s chair. Bruser has served on the board of The Merola Opera Program for almost 30 years, and also serves on The Archer School for Girls Board of Trustees. She is a graduate of University of California, Santa Barbara and University of Western Ontario.
Fink also has extensive business experience. He is currently vice chairman of Heron International, a real estate company headquartered in London, chairman of Life Storage LLC, and a member of the board of directors of K-12, a New York Stock Exchange-listed virtual charter school company. Fink has served in numerous other positions, including as former chief executive officer of Lawrence Investments, a venture with Oracle co-founder Larry Ellison that owns and manages Ellison’s non-Oracle investments, and was a founding partner, managing director and vice chairman of Knowledge Universe (now KinderCare Education), which focuses on educational companies and is one of the world’s largest for profit education companies.
Fink is a member of the Herb Ritts Foundation board and the photographic counsel of the Getty Museum. He is a previous member of The American College of Physicians Foundation, the board of the Smithsonian Institute Museum of American History and the UCLA Foundation board.
Post is chairman of the board of TGen, a leading biomedical research institute that recently formed an alliance with City of Hope, and serves on the board of directors for First Solar Corporation and Blue Cross Blue Shield. He is retired as chairman and chief executive officer of Pinnacle West Capital Corporation.
Post brings extensive leadership experience to City of Hope, having served as chairman of several companies, including Swift Transportation, Suncor Development Company and Stagg Information Systems. He has also served as chairman of several boards, including the Business Coalition, Greater Phoenix Leadership and Greater Phoenix Economic Council. Post is currently chairman of the board of the Arizona State University Foundation, where he received a Bachelor of Science degree.
About City of Hope
City of Hope is an independent research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as one of only 47 comprehensive cancer centers, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the world. City of Hope is located in Duarte, California, just northeast of Los Angeles, with community clinics
throughout Southern California. It is ranked as one of "America's Best Hospitals" in cancer by U.S. News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation
and numerous breakthrough cancer drugs
based on technology developed at the institution. For more information about City of Hope, follow us on Facebook
# # #